Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers
Research and Markets: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014
Research and Markets: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014
Research and Markets: Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014
Research and Markets: Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch
Research and Markets: PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 for the $23 Billion Industry
Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants
Week ending April 27: Quarterly earnings continue to boost market's spirits.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.